NASDAQ:GANX | Key Financial Ratios | Gain Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-304.360.03-130.37%-178.06%
2026-03-314.690.03-113.35%-151.64%
2025-12-316.630.02-88.35%-108.60%
2025-09-302.520.07-176.74%-328.15%
2025-06-301.790.12-189.07%-503.05%
2025-03-312.220.07-180.03%-362.08%
2024-12-312.970.06-168.36%-278.10%
2024-09-302.990.06-148.74%-239.83%
2024-06-302.840.04-112.52%-183.28%
2024-03-312.770.06-145.05%-244.67%
2023-12-313.590.05-119.66%-177.03%
2023-09-302.30.07-157.60%-303.08%
2023-06-303.10.05-120.79%-198.85%
2023-03-313.750.04-91.24%-128.51%
2022-12-315.110.03-72.99%-93.17%
2022-09-305.620.03-56.97%-71.20%
2022-06-307.580.02-50.93%-60.12%
2022-03-318.630.02-39.13%-46.23%
2021-12-3114.780.02-35.63%-39.90%
2021-09-3011.620.02-28.96%-32.83%
2021-06-3018.090.02-18.65%-20.43%
2021-03-3120.370.02-11.33%-12.24%
2020-12-314.250.12-37.25%-57.69%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-316.630.02-88.35%-108.60%
2024-12-312.970.06-168.36%-278.10%
2023-12-313.590.05-119.66%-177.03%
2022-12-315.110.03-72.99%-93.17%
2021-12-3114.780.02-35.63%-39.90%
2020-12-314.250.12-37.25%-57.69%